ARTICLE | Distillery Therapeutics
Cardiovascular
May 23, 2017 8:32 PM UTC
Mouse studies suggest inhibiting FGF13 could help treat cardiomyopathy. In a mouse model of pressure overload-induced cardiac hypertrophy, cardiac-specific FGF13 knockout increased fractional shorteni...
BCIQ Target Profiles